Dexamethasone liposomal - InnoMedica

Drug Profile

Dexamethasone liposomal - InnoMedica

Alternative Names: TLDex

Latest Information Update: 22 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator InnoMedica
  • Class Anti-inflammatories; Antiemetics; Antineoplastics; Fluorinated steroids; Glucocorticoids; Pregnadienetriols; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Suspended Ocular inflammation

Most Recent Events

  • 22 May 2017 Suspended - Preclinical for Ocular inflammation in Switzerland (IV) (InnoMedica communication, May 2017)
  • 12 May 2017 Chemical structure information added
  • 25 Apr 2017 Preclinical trials in Ocular inflammation in Switzerland (IV) (Innomedica pipeline, April 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top